- Home
- SQFT vs CSCI Comparison
SQFT vs CSCI Comparison
Compare SQFT & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- CSCI
- Stock Information
- Founded
- SQFT 1999
- CSCI 1990
- Country
- SQFT United States
- CSCI Canada
- Employees
- SQFT N/A
- CSCI N/A
- Industry
- SQFT Real Estate Investment Trusts
- CSCI
- Sector
- SQFT Real Estate
- CSCI
- Exchange
- SQFT Nasdaq
- CSCI NYSE
- Market Cap
- SQFT 9.8M
- CSCI 11.1M
- IPO Year
- SQFT 2020
- CSCI 1996
- Fundamental
- Price
- SQFT $0.85
- CSCI $2.50
- Analyst Decision
- SQFT
- CSCI
- Analyst Count
- SQFT 0
- CSCI 0
- Target Price
- SQFT N/A
- CSCI N/A
- AVG Volume (30 Days)
- SQFT 207.8K
- CSCI 4.1K
- Earning Date
- SQFT 12-31-2024
- CSCI 11-12-2024
- Dividend Yield
- SQFT N/A
- CSCI N/A
- EPS Growth
- SQFT N/A
- CSCI N/A
- EPS
- SQFT N/A
- CSCI N/A
- Revenue
- SQFT $18,586,052.00
- CSCI $4,834,000.00
- Revenue This Year
- SQFT N/A
- CSCI N/A
- Revenue Next Year
- SQFT N/A
- CSCI N/A
- P/E Ratio
- SQFT N/A
- CSCI N/A
- Revenue Growth
- SQFT 5.44
- CSCI N/A
- 52 Week Low
- SQFT $0.47
- CSCI $2.50
- 52 Week High
- SQFT $1.39
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- SQFT 62.25
- CSCI N/A
- Support Level
- SQFT $0.71
- CSCI N/A
- Resistance Level
- SQFT $0.88
- CSCI N/A
- Average True Range (ATR)
- SQFT 0.09
- CSCI 0.00
- MACD
- SQFT 0.02
- CSCI 0.00
- Stochastic Oscillator
- SQFT 91.46
- CSCI 0.00
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.